A sofosbuvir-based direct-acting antiviral treatment regimen exhibits a strong protective effect against post-liver transplantation chronic hepatitis C recurrenceAtsushi Oyama, Hiroyuki Okada, Tetsuya Yasunaka et al.|Kanzo|2017Cited by 0